Document Detail

Salivary and serum beta2-microglobulin and gamma-glutamyl-transferase in patients with primary Sjögren syndrome and Sjögren syndrome secondary to systemic lupus erythematosus.
MedLine Citation:
PMID:  12867296     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Sialochemistry has been proposed as a simple and useful tool for the diagnosis of Sjögren syndrome (SS). Although many changes have been detected in several constituents of saliva from patients with SS, none are individually sensitive or specific enough for diagnosing SS. The aim of this study was to assess the value of the combined determination of beta2-microglobulin (beta2m) and gamma-glutamyl-transferase (GGT) activity in serum and saliva as a diagnostic instrument for differentiating primary and secondary [to systemic lupus erythematosus (SLE)] SS patients from normal subjects. METHODS: Nineteen primary SS (pSS) patients, 15 patients with SS secondary to SLE, and 25 SLE patients without SS were studied. Thirty healthy subjects were included in the study as control group. RESULTS: By means of a mathematical model, (a) 84.1%, (b) 85.7%, and (c) 87.0% of patients were correctly classified as SS or normal when (a) salivary beta2m and GGT values, (b) serum beta2m and salivary GGT values, and (c) salivary beta2m and GGT along with serum beta2m values, respectively, were considered. To differentiate between pSS and sSS by means of the mathematical model, the combination of serum beta2m and salivary GGT values achieved that 81.8% of the patients were correctly classified. CONCLUSION: Since sialochemistry is an easy, safe and reliable test, the combined determination of beta2m and GGT in saliva and serum was useful for differentiating SS patients from normal subjects, but not excessively good for differentiating pSS from sSS patients.
José Castro; Juan Jiménez-Alonso; José Mario Sabio; Francisco Rivera-Cívico; María Martín-Armada; Miguel Angel Rodríguez; Laura Jáimez; María Jesús Castillo; Julio Sánchez-Román;
Related Documents :
21324816 - Positive prolactin response to bromocriptine in 2 patients with cabergoline-resistant p...
3264576 - Association of hla-dr2/dr4 heterozygosity with systemic lupus erythematosus in japanese...
6802356 - Hydralazine, antinuclear antibodies, and the lupus syndrome.
4037886 - Decreased nailfold capillary density in raynaud's phenomenon: a reflection of immunolog...
1717096 - Screening for prostate cancer. comparison of transrectal ultrasound, prostate specific ...
8504396 - Incidence of chromosome abnormalities and clinical significance of karyotype in de novo...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Clinica chimica acta; international journal of clinical chemistry     Volume:  334     ISSN:  0009-8981     ISO Abbreviation:  Clin. Chim. Acta     Publication Date:  2003 Aug 
Date Detail:
Created Date:  2003-07-17     Completed Date:  2003-12-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  1302422     Medline TA:  Clin Chim Acta     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  225-31     Citation Subset:  IM    
Services of Internal Medicine, Virgen de las Nieves University Hospital, Jefe de Servicio de Medicina Interna, Avda. Fuerzas Armadas, 2, 18014, Granada, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers
Lupus Erythematosus, Systemic / complications,  enzymology,  metabolism*
Middle Aged
Saliva / chemistry*
Sjogren's Syndrome / enzymology,  etiology,  metabolism*
beta 2-Microglobulin / blood,  metabolism*
gamma-Glutamyltransferase / blood,  metabolism*
Reg. No./Substance:
0/Biological Markers; 0/beta 2-Microglobulin; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reactivity of agalactosyl IgG with rheumatoid factor.
Next Document:  Characterization of molecular forms of probrain natriuretic peptide in human plasma.